9 | Biomarkers (Surrogate Marker)IBA
07/2023
-
04/2012 |
5 | AntigensIBA
06/2023
-
10/2011 |
4 | RadiopharmaceuticalsIBA
04/2015
-
01/2008 |
3 | Trastuzumab (Herceptin)FDA Link
12/2023
-
01/2010 |
3 | Deferoxamine (Desferal)FDA LinkGeneric
10/2022
-
10/2010 |
3 | EnzymesIBA
04/2014
-
04/2009 |
3 | Proteins (Proteins, Gene)FDA Link
04/2014
-
01/2013 |
3 | CopperIBA
04/2009
-
02/2006 |
2 | human ERBB2 proteinIBA
12/2023
-
06/2013 |
2 | Prostate-Specific Antigen (Semenogelase)IBA
07/2023
-
04/2012 |
2 | Peptides (Polypeptides)IBA
06/2023
-
02/2014 |
2 | Rotaxanes (Rotaxane)IBA
06/2023
-
11/2022 |
2 | Radioisotopes (Radionuclides)IBA
11/2022
-
01/2010 |
2 | onartuzumabIBA
06/2022
-
01/2019 |
2 | Monoclonal AntibodiesIBA
03/2022
-
10/2011 |
2 | MetalsIBA
04/2015
-
04/2014 |
2 | Chelating AgentsIBA
04/2015
-
02/2014 |
2 | Biphenyl CompoundsIBA
04/2013
-
01/2013 |
2 | EpitopesIBA
10/2011
-
10/2010 |
1 | bispidineIBA
12/2023 |
1 | Estrogen ReceptorsIBA
12/2023 |
1 | Bombesin Receptors (Bombesin Receptor)IBA
12/2023 |
1 | Designed Ankyrin Repeat ProteinsIBA
07/2023 |
1 | Hormones (Hormone)IBA
07/2023 |
1 | Fluorescein (Funduscein)FDA LinkGeneric
06/2023 |
1 | sortase AIBA
10/2022 |
1 | glycyl-glycyl-glycine (triglycine)IBA
10/2022 |
1 | AzidesIBA
03/2022 |
1 | IntegrinsIBA
01/2021 |
1 | Proto-Oncogene Proteins c-metIBA
01/2020 |
1 | Urea (Carbamide)FDA LinkGeneric
01/2017 |
1 | Brentuximab VedotinIBA
01/2016 |
1 | Immunoconjugates (Immunoconjugate)IBA
01/2016 |
1 | Fluorine-18IBA
04/2015 |
1 | Glycogen Synthase (Synthase I)IBA
04/2014 |
1 | Cholinergic Agents (Cholinergics)IBA
04/2014 |
1 | Monoamine Oxidase (MAO)IBA
04/2014 |
1 | Cannabinoid Receptors (Cannabinoid Receptor)IBA
04/2014 |
1 | tau Proteins (tau Protein)IBA
04/2014 |
1 | FibrinIBA
02/2014 |
1 | 1,8- (2,6- pyridinedimethylene)- 1,4,8,11- tetraazacyclotetradecane- 2,4- diacetic acidIBA
02/2014 |
1 | AfatinibIBA
06/2013 |
1 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
06/2013 |
1 | Tyrosine Kinase InhibitorsIBA
06/2013 |
1 | zirconium-89-trastuzumabIBA
06/2013 |
1 | ErbB Receptors (EGF Receptor)IBA
06/2013 |
1 | BromidesIBA
04/2013 |
1 | diphenyl (biphenyl)IBA
04/2013 |
1 | Bromodeoxyuridine (BrdU)IBA
01/2013 |
1 | Transferrin (beta 2 Transferrin)IBA
01/2013 |
1 | Ion Channels (Ion Channel)IBA
01/2013 |
1 | Androgen Receptors (Androgen Receptor)IBA
04/2012 |
1 | Serum AlbuminIBA
04/2011 |
1 | E4G10 antibodyIBA
10/2010 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
10/2010 |
1 | cadherin 5IBA
10/2010 |
1 | AcidsIBA
10/2010 |
1 | Carbon Nanotubes (Carbon Nanotube)IBA
10/2010 |
1 | 6- amino- 8- ((6- iodo- 1,3- benzodioxol- 5- yl)thio)- N- (1- methylethyl)- 9H-purine-9-propanamineIBA
01/2010 |
1 | AnionsIBA
04/2009 |
1 | LigandsIBA
04/2009 |
1 | NAD (NADH)IBA
04/2009 |
1 | copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA
04/2009 |
1 | Oxygen (Dioxygen)IBA
11/2008 |
1 | Glucose (Dextrose)FDA LinkGeneric
11/2008 |
1 | SolutionsIBA
02/2006 |